$3.01 Billion is the total value of Avidity Partners Management LP's 83 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| REGN | New | REGENERON PHARMACEUTICALS | $97,860,897 | – | 119,100 | +100.0% | 3.25% | – |
| BDX | New | BECTON DICKINSON & CO | $71,291,520 | – | 288,000 | +100.0% | 2.37% | – |
| ZTS | New | ZOETIS INCcl a | $67,824,300 | – | 407,500 | +100.0% | 2.25% | – |
| MRK | New | MERCK & CO INC | $63,834,000 | – | 600,000 | +100.0% | 2.12% | – |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $44,149,908 | – | 3,812,600 | +100.0% | 1.46% | – |
| ABT | New | ABBOTT LABS | $35,846,040 | – | 354,000 | +100.0% | 1.19% | – |
| BIIB | New | BIOGEN INC | $35,810,264 | – | 128,800 | +100.0% | 1.19% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $29,227,913 | – | 300,575 | +100.0% | 0.97% | – |
| ETNB | New | 89BIO INC | $28,068,524 | – | 1,842,976 | +100.0% | 0.93% | – |
| New | AMYLYX PHARMACEUTICALS INC | $26,406,000 | – | 900,000 | +100.0% | 0.88% | – | |
| CVAC | New | CUREVAC N V | $24,743,500 | – | 3,550,000 | +100.0% | 0.82% | – |
| AVTR | New | AVANTOR INC | $23,782,500 | – | 1,125,000 | +100.0% | 0.79% | – |
| FUSN | New | FUSION PHARMACEUTICALS INC | $21,489,000 | – | 5,700,000 | +100.0% | 0.71% | – |
| ABC | New | AMERISOURCEBERGEN CORP | $20,269,926 | – | 126,600 | +100.0% | 0.67% | – |
| New | MINERALYS THERAPEUTICS INC | $19,791,108 | – | 1,263,800 | +100.0% | 0.66% | – | |
| VRNA | New | VERONA PHARMA PLCsponsored ads | $17,646,304 | – | 878,800 | +100.0% | 0.59% | – |
| BBIO | New | BRIDGEBIO PHARMA INC | $16,580,000 | – | 1,000,000 | +100.0% | 0.55% | – |
| IMVT | New | IMMUNOVANT INC | $16,176,930 | – | 1,043,000 | +100.0% | 0.54% | – |
| MRSN | New | MERSANA THERAPEUTICS INC | $14,110,588 | – | 3,433,233 | +100.0% | 0.47% | – |
| GERN | New | GERON CORP | $4,617,760 | – | 2,128,000 | +100.0% | 0.15% | – |
| PRAX | New | PRAXIS PRECISION MEDICINES I | $3,463,895 | – | 4,281,700 | +100.0% | 0.12% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 15 | Q3 2023 | 4.6% |
| ARVINAS INC | 14 | Q3 2023 | 4.9% |
| ZENTALIS PHARMACEUTICALS INC | 14 | Q3 2023 | 4.8% |
| SYNDAX PHARMACEUTICALS INC | 14 | Q3 2023 | 3.2% |
| IDEAYA BIOSCIENCES INC | 13 | Q3 2023 | 2.5% |
| NATERA INC | 13 | Q3 2023 | 1.9% |
| ALPINE IMMUNE SCIENCES INC | 13 | Q3 2023 | 0.5% |
| ABBVIE INC | 12 | Q2 2023 | 9.7% |
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 3.4% |
| AVANTOR INC | 11 | Q1 2023 | 6.0% |
View Avidity Partners Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adicet Bio, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ALPINE IMMUNE SCIENCES, INC. | February 14, 2023 | 1,888,887 | 4.0% |
| ESSA Pharma Inc. | February 14, 2023 | 1,855,400 | 4.2% |
| Gritstone bio, Inc. | February 14, 2023 | 2,859,971 | 3.3% |
| IVERIC bio, Inc. | February 14, 2023 | 838,407 | 0.6% |
| ONCOSEC MEDICAL IncSold out | February 14, 2023 | 0 | 0.0% |
| PhaseBio Pharmaceuticals Inc | February 14, 2023 | 2,040,000 | 4.1% |
| Phathom Pharmaceuticals, Inc. | February 14, 2023 | 1,900,000 | 4.6% |
| Viridian Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Anika Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Avidity Partners Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-09 |
| SC 13G | 2024-03-27 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Avidity Partners Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.